Dr. Reitman leverages her understanding of the fundamental principles of materials science and the technology of macromolecules to assess risk and performance for end users, distributors, manufacturers, product designers and raw material suppliers across a wide range of industries. Her expertise includes polymer and composite technology, mechanics of materials, adhesion science, fiber mechanics, history and technology of plastics, and material failure analysis. She is skilled in the development and use of testing tools and methods and has applied them to plastics, rubber, textile, metal, glass, ceramic, and composite materials and systems. She is experienced in major aspects of product development, including materials selection, formulation, scale-up, end-use testing, failure analysis, certification procedures and issues related to intellectual property.
Dr. Reitman has conducted research in the areas of medical plastics and devices including implants, diagnostic components, and transdermal drug delivery systems; plastic packaging and barrier materials; paints and coatings; plastic pipes; spray foam insulation; adhesives, sealants, and encapsulants; additive manufacturing / 3D printing; molding compounds; composite materials; high temperature resins; rubber gaskets and seals; nanoparticles; fibers and textiles; polymer chemical resistance; wire and cable insulation; connectors and splices; environmental effects on durability; and product aging. She has used her expertise to address problems and opportunities related to coatings, fibers, films, and extruded and molded products, and their use in the telecom, electronics, electrical, energy, transportation, construction, fire protection, medical, and consumer products markets. Dr. Reitman also assists clients with matters related to intellectual property, including support related to patent filings, technical due diligence, and technical aspects of trade secret, patent infringement, and patent validity disputes.
Dr. Reitman is active in technical and business advisory roles. She has served on technical advisory boards for materials and manufacturing companies as well as in several Board of Directors positions for the Medical Plastics Division and the Failure Analysis and Prevention Special Interest Group of the Society of Plastics Engineers. Dr. Reitman is also a voting member of two Underwriters Laboratories Standard Technical Panels, addressing Polymeric Materials (UL 94, UL 746, UL 1694) and Appliance Wiring (UL758).
Prior to joining Exponent, Dr. Reitman worked for the 3M Company in both research and management roles. Her activities included technology identification, materials selection and qualification, product development, customer support, program management, acquisition integration, staff and organizational development, intellectual property analysis, and patent litigation support.
What is Maureen T. F. Reitman's net worth?
The estimated net worth of Maureen T. F. Reitman is at least $2.60 million as of November 24th, 2023. Dr. Reitman owns 28,729 shares of Exponent stock worth more than $2,604,858 as of December 21st. This net worth estimate does not reflect any other investments that Dr. Reitman may own. Additionally, Dr. Reitman receives a salary of $1,110,000.00 as VP at Exponent. Learn More about Maureen T. F. Reitman's net worth.
How old is Maureen T. F. Reitman?
Dr. Reitman is currently 55 years old. There are 4 older executives and no younger executives at Exponent. The oldest executive at Exponent is Dr. Subbaiah V. Malladi P.E., Ph.D., CTO & Principal Engineer, who is 77 years old. Learn More on Maureen T. F. Reitman's age.
What is Maureen T. F. Reitman's salary?
As the VP of Exponent, Inc., Dr. Reitman earns $1,110,000.00 per year. The highest earning executive at Exponent is Dr. Catherine Ford Corrigan P.E., Ph.D., President, CEO & Director, who commands a salary of $1,670,000.00 per year. Learn More on Maureen T. F. Reitman's salary.
How do I contact Maureen T. F. Reitman?
Has Maureen T. F. Reitman been buying or selling shares of Exponent?
Maureen T. F. Reitman has not been actively trading shares of Exponent during the last quarter. Most recently, Maureen T. F. Reitman sold 2,000 shares of the business's stock in a transaction on Friday, November 24th. The shares were sold at an average price of $78.25, for a transaction totalling $156,500.00. Following the completion of the sale, the vice president now directly owns 28,729 shares of the company's stock, valued at $2,248,044.25. Learn More on Maureen T. F. Reitman's trading history.
Who are Exponent's active insiders?
Exponent's insider roster includes George Brown (Director), Eric Guyer (Insider), Bradley James (VP), Paul Johnston (Director), Harri Kytömaa (VP), Carol Lindstrom (Director), Steven Murray (VP), John Pye (VP), Joseph Rakow (VP), Richard Reiss (VP), Maureen Reitman (VP), Richard Schlenker, Jr. (CFO), and Sally Shepard (Insider). Learn More on Exponent's active insiders.
Are insiders buying or selling shares of Exponent?
In the last twelve months, insiders at the business services provider sold shares 18 times. They sold a total of 87,729 shares worth more than $8,517,716.79. The most recent insider tranaction occured on November, 20th when Director Paul R Johnston sold 1,300 shares worth more than $123,539.00. Insiders at Exponent own 2.1% of the company.
Learn More about insider trades at Exponent. Information on this page was last updated on 11/20/2024.